biotechnology

Aerska Therapeutics Secures $39 Million to Advance Iron‑Based Brain‑Targeted Gene Silencing Platform

by

The Future of Brain-Targeted RNA Therapies: A Recent Era in Neurological Disease Treatment Aerska Therapeutics, a Dublin and London-based biotech startup, is pioneering a novel approach to treating neurological diseases by delivering RNA interference (RNAi) therapies directly to the brain. Recent financing rounds, totaling $39 million, highlight growing investor confidence in this innovative technology. This … Read more

New nanoparticle separation method boosts biotech and cancer research

by

Nanoparticle Revolution: New Separation Technique Poised to Transform Biotech and Cancer Research A significant hurdle in nanoscale particle research – the accurate separation and purification of particles smaller than a few hundred nanometers – has been overcome by researchers at the University of Oulu. This breakthrough promises to accelerate advancements in biotechnology, diagnostics, and particularly, … Read more

TrumpRx: Are the Drug Prices Really the Lowest?

by

TrumpRx: A Discount Drug Platform or Just a Clever Illusion? WASHINGTON — President Trump’s recently launched TrumpRx website promises the “lowest prices anywhere in the world” for prescription drugs. Though, a closer look reveals a more complex picture. Whereas the platform offers discounts on 43 brand-name drugs, a significant portion – at least 22 – … Read more

Nektar Therapeutics: Eczema Data Could Shift Risk-Reward Balance

by

The Eczema Treatment Landscape: Beyond Dupixent and Ebglyss Nektar Therapeutics’ upcoming Phase 2 maintenance results for rezpeg in moderate-to-severe eczema (atopic dermatitis) are arriving at a pivotal moment. With the stock down over 40% since November, investors are keenly watching for data that could redefine the risk-reward profile. But this isn’t just about one company; … Read more

More about MSCs stem cells | Mediland

by

The Future of Regenerative Medicine: Beyond Stem Cells to Secretomes For years, stem cell therapy has held immense promise for treating a vast range of diseases. But a fascinating shift is underway. Researchers are increasingly focusing not on the cells themselves, but on what they *release* – a complex cocktail of signaling molecules known as … Read more

Pfizer (PFE) earnings Q4 2025

by

Pfizer’s Pivot: Navigating a Post-COVID World and the Future of Pharma Pfizer’s recent fourth-quarter earnings report, while exceeding Wall Street expectations, paints a clear picture: the era of blockbuster COVID-19 revenue is waning. The company is now aggressively shifting its focus, and its future hinges on strategic acquisitions, cost-cutting measures, and navigating a complex landscape … Read more

FDA Urges Long-Term Monitoring of CAR-T Therapy for Autoimmune Diseases | STAT

by

The Looming Shadow Over CAR-T: Long-Term Risks and the Future of Autoimmune Therapies The FDA is signaling a critical shift in how it evaluates CAR-T cell therapies, not just for cancer, but increasingly for autoimmune diseases. A recent op-ed in the Annals of Internal Medicine, penned by FDA officials, highlights a growing concern: the potential … Read more

Eli Lilly CEO David Ricks talks Medicare coverage of obesity pills

by

The Obesity Drug Revolution: How Medicare Coverage and Trump’s Plan Could Reshape the Market The landscape of obesity treatment is poised for a dramatic shift. Eli Lilly CEO Dave Ricks recently signaled that upcoming Medicare coverage, coupled with pricing agreements struck with the Trump administration, could be a game-changer for the rollout of their experimental … Read more

Pharma & Biotech Moves: Nick Vlahakis to Magnet Biomedicine

by

The Revolving Door in Biotech: Why CMO Moves Signal Bigger Trends The recent appointment of Nick Vlahakis as Chief Medical Officer at Magnet Biomedicine, following his tenure at CohBar, isn’t just a personnel shift. It’s a microcosm of a larger trend: increased movement at the executive level within the pharmaceutical and biotechnology industries. This constant … Read more

Blood protein albumin identified as key defense against deadly black fungus

by

The Unexpected Shield Against ‘Black Fungus’: How Albumin Could Revolutionize Mucormycosis Treatment A groundbreaking new study published in Nature has revealed a surprising defender against mucormycosis, a devastating fungal infection often referred to as “black fungus.” Researchers have identified albumin, the most abundant protein in human blood, as a key component of the body’s natural … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: [email protected]

For contact, advertising, copyright, issues email: [email protected]